Client compliance is one of the biggest challenges that clinicians face when recommending treatment for any medical problem. The reality is that many pet owners are hard pressed to adhere to a TID administration of any treatment for their pet. In the case of a seizure disorder, noncompliance in administering an anticonvulsant has serious consequences for the pet.
An extended release formulation of levetiracetam (Keppra ER) is available for managing epilepsy in humans. The subject of this week's Evidence Based Update is anticonvulsant therapy - with an emphasis on this particular drug. Discussion includes:
- Findings of a recent study on the disposition of extended release levetiracetam (Keppra ER) in dogs
- Recommended dosing of Keppra ER
- Whether giving the medication with food vs. on an empty stomach makes a difference
- Expected side effects
- Recommended monitoring of patients
Running time: 14 mins
Read more on this topic:
http://vetvine.com/forums/topic/569/anticonvulsant-therapy-in-dogs
Member fee: $14.95; Free registration for new Members, Unlimited Plus members and Evidence Based Update subscribers (
https://www.vetvine.com/article/181/evidence-based-update-subscriptions)
